Showing 8,761 - 8,780 results of 99,477 for search '(( 5 a decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (nn decrease)) ))', query time: 1.26s Refine Results
  1. 8761

    Regional tricuspid annular perimeter. by Paulina Kania-Olejnik (19797617)

    Published 2024
    “…Annular height marginally decreased with AF from 5.8±1.9mm to 5.7±2.0mm; <i>p</i> = 0.039.…”
  2. 8762
  3. 8763
  4. 8764
  5. 8765
  6. 8766
  7. 8767
  8. 8768
  9. 8769
  10. 8770
  11. 8771
  12. 8772
  13. 8773
  14. 8774

    Table_5_Overpressure Exposure From .50-Caliber Rifle Training Is Associated With Increased Amyloid Beta Peptides in Serum.DOCX by Bharani Thangavelu (7224311)

    Published 2020
    “…Therefore, development of quantitative and objective OP-mediated effects during acute timeframes would vastly augment point-of-care or field-based decisions. This pilot study evaluated the amplitude of traumatic brain injury (TBI)–associated biomarkers in serum as a consequence of repeated OP exposure from .50-caliber rifle use over training multiple days.…”
  15. 8775
  16. 8776

    Image_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  17. 8777

    Table_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  18. 8778

    Table_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  19. 8779

    Table_3_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  20. 8780

    Image_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”